105 related articles for article (PubMed ID: 11063839)
1. Increased cellular expression of the caspase inhibitor FLIP in intrathecal lymphocytes from patients with multiple sclerosis.
Sharief MK
J Neuroimmunol; 2000 Nov; 111(1-2):203-9. PubMed ID: 11063839
[TBL] [Abstract][Full Text] [Related]
2. The expression of pro- and anti-apoptosis Bcl-2 family proteins in lymphocytes from patients with multiple sclerosis.
Sharief MK; Douglas M; Noori M; Semra YK
J Neuroimmunol; 2002 Apr; 125(1-2):155-62. PubMed ID: 11960652
[TBL] [Abstract][Full Text] [Related]
3. The expression of apoptosis-regulatory proteins in B lymphocytes from patients with multiple sclerosis.
Seidi OA; Sharief MK
J Neuroimmunol; 2002 Sep; 130(1-2):202-10. PubMed ID: 12225903
[TBL] [Abstract][Full Text] [Related]
4. Enhanced expression of Fas-associated death domain-like IL-1-converting enzyme (FLICE)-inhibitory protein induces resistance to Fas-mediated apoptosis in activated mast cells.
Yoshikawa H; Nakajima Y; Tasaka K
J Immunol; 2000 Dec; 165(11):6262-9. PubMed ID: 11086061
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of the apoptosis inhibitor FLIP in T cells correlates with disease activity in multiple sclerosis.
Semra YK; Seidi OA; Sharief MK
J Neuroimmunol; 2001 Feb; 113(2):268-74. PubMed ID: 11164911
[TBL] [Abstract][Full Text] [Related]
6. Interferon-beta therapy downregulates the anti-apoptosis protein FLIP in T cells from patients with multiple sclerosis.
Sharief MK; Semra YK; Seidi OA; Zoukos Y
J Neuroimmunol; 2001 Nov; 120(1-2):199-207. PubMed ID: 11694335
[TBL] [Abstract][Full Text] [Related]
7. Upregulated survivin expression in activated T lymphocytes correlates with disease activity in multiple sclerosis.
Sharief MK; Noori MA; Douglas MR; Semra YK
Eur J Neurol; 2002 Sep; 9(5):503-10. PubMed ID: 12220382
[TBL] [Abstract][Full Text] [Related]
8. Fas aggregation does not correlate with Fas-mediated apoptosis.
Lee Y; Shacter E
J Immunol; 2001 Jul; 167(1):82-9. PubMed ID: 11418635
[TBL] [Abstract][Full Text] [Related]
9. The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways.
Kataoka T; Budd RC; Holler N; Thome M; Martinon F; Irmler M; Burns K; Hahne M; Kennedy N; Kovacsovics M; Tschopp J
Curr Biol; 2000 Jun; 10(11):640-8. PubMed ID: 10837247
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of TCR-induced CD8 T cell death by IL-12: regulation of Fas ligand and cellular FLIP expression and caspase activation by IL-12.
Lee SW; Park Y; Yoo JK; Choi SY; Sung YC
J Immunol; 2003 Mar; 170(5):2456-60. PubMed ID: 12594270
[TBL] [Abstract][Full Text] [Related]
11. Intracellular regulation of Fas-induced apoptosis in human fibroblasts by extracellular factors and cycloheximide.
Santiago B; Galindo M; Palao G; Pablos JL
J Immunol; 2004 Jan; 172(1):560-6. PubMed ID: 14688367
[TBL] [Abstract][Full Text] [Related]
12. Transition of apoptotic resistant vascular smooth muscle cells to troptotic sensitive state is correlated with downregulation of c-FLIP.
Imanishi T; Hano T; Nishio I; Liles WC; Schwartz SM; Han DK
J Vasc Res; 2000; 37(6):523-31. PubMed ID: 11146406
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the Fas death pathway by FLICE-inhibitory protein in primary human B cells.
Hennino A; Berard M; Casamayor-Pallejà M; Krammer PH; Defrance T
J Immunol; 2000 Sep; 165(6):3023-30. PubMed ID: 10975811
[TBL] [Abstract][Full Text] [Related]
14. Fas-mediated apoptosis in neuroblastoma requires mitochondrial activation and is inhibited by FLICE inhibitor protein and Bcl-2.
Poulaki V; Mitsiades N; Romero ME; Tsokos M
Cancer Res; 2001 Jun; 61(12):4864-72. PubMed ID: 11406564
[TBL] [Abstract][Full Text] [Related]
15. Theileria parva-transformed T cells show enhanced resistance to Fas/Fas ligand-induced apoptosis.
Küenzi P; Schneider P; Dobbelaere DA
J Immunol; 2003 Aug; 171(3):1224-31. PubMed ID: 12874209
[TBL] [Abstract][Full Text] [Related]
16. Constitutive caspase activation and impaired death-inducing signaling complex formation in CD95-resistant, long-term activated, antigen-specific T cells.
Strauss G; Knape I; Melzner I; Debatin KM
J Immunol; 2003 Aug; 171(3):1172-82. PubMed ID: 12874203
[TBL] [Abstract][Full Text] [Related]
17. Impaired Fas-independent apoptosis of T lymphocytes in patients with multiple sclerosis.
Sharief MK
J Neuroimmunol; 2000 Sep; 109(2):236-43. PubMed ID: 10996226
[TBL] [Abstract][Full Text] [Related]
18. Resistance to Fas-mediated apoptosis in human lung fibroblast.
Tanaka T; Yoshimi M; Maeyama T; Hagimoto N; Kuwano K; Hara N
Eur Respir J; 2002 Aug; 20(2):359-68. PubMed ID: 12212968
[TBL] [Abstract][Full Text] [Related]
19. Resistance of short term activated T cells to CD95-mediated apoptosis correlates with de novo protein synthesis of c-FLIPshort.
Schmitz I; Weyd H; Krueger A; Baumann S; Fas SC; Krammer PH; Kirchhoff S
J Immunol; 2004 Feb; 172(4):2194-200. PubMed ID: 14764686
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of the inhibitor of apoptosis proteins in activated T lymphocytes from patients with multiple sclerosis.
Sharief MK; Semra YK
J Neuroimmunol; 2001 Oct; 119(2):350-7. PubMed ID: 11585639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
